iShares U.S. Healthcare Providers ETF
IHF - ETF AI Analysis
Top Page
iShares U.S. Healthcare Providers ETF (IHF)
IHF, the iShares U.S. Healthcare Providers ETF, earns a solid overall rating thanks to major holdings like UnitedHealth, Elevance Health, and Quest Diagnostics, which bring strong financial performance, attractive valuations, and positive growth initiatives in areas like technology and advanced diagnostics. The fund is somewhat held back by weaker names such as Centene and CVS, where profitability, leverage, and valuation concerns add pressure. The main risk is the ETF’s concentration in U.S. healthcare providers, meaning sector-specific challenges in areas like Medicare, Medicaid, and ACA markets can significantly impact overall performance.
IHF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.58B
- Region
- North America
- Expense Ratio
- 0.37%
- Beta
- 0.47
- Issuer
- iShares
- Inception Date
- May 01, 2006
- Dividend Yield
- 0.90%
- Asset Class
- Equity
- Index Tracked
- DJ US Select / Health Care Providers
IHF Summary
IHF is the iShares U.S. Healthcare Providers ETF, which follows the DJ US Select / Health Care Providers index. It invests in U.S. companies that deliver medical services and run healthcare facilities, such as hospitals and health insurance firms. Well-known holdings include UnitedHealth and CVS Health. Investors might consider IHF for diversification and potential long-term growth driven by an aging population and steady demand for healthcare services. However, this ETF is concentrated in the healthcare providers sector, so its value can go up and down based on changes in healthcare policy, costs, and overall stock market conditions.
How much will it cost me?
This ETF has an expense ratio of 0.37%, which means you’ll pay about $3.70 per year for every $1,000 invested. That’s higher than many broad, low-cost index ETFs because this fund focuses on a more specialized slice of the healthcare sector, which typically comes with slightly higher fees.
What would affect this ETF?
IHF could benefit from an aging U.S. population, steady demand for medical services, and any supportive healthcare policies, which may help major holdings like UnitedHealth, CVS Health, and other insurers and hospital operators. On the downside, changes in government reimbursement, healthcare reform that pressures insurance profits, or broader economic weakness that reduces healthcare spending could hurt these U.S.-focused healthcare providers and services companies.
IHF Top 10 Holdings
IHF is essentially a bet on U.S. healthcare providers, with UnitedHealth and Elevance Health steering the ship. UnitedHealth has been steady but not spectacular lately, while Elevance is rising and helping support the fund’s momentum. On the services side, Veeva Systems and Labcorp have been strong climbers, adding a tech-and-diagnostics tailwind. CVS Health, however, has been lagging and occasionally drags on overall returns. With nearly all holdings U.S.-based and tightly focused on health insurers, hospitals, and diagnostics, this ETF is a concentrated play on the American healthcare system.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| UnitedHealth | 21.89% | $346.41M | $365.09B | 22.54% | 72Outperform | |
| CVS Health | 11.61% | $183.63M | $114.32B | 12.76% | 64Neutral | |
| Elevance Health | 9.45% | $149.56M | $92.84B | 30.89% | 76Outperform | |
| HCA Healthcare | 5.00% | $79.07M | $104.25B | 5.44% | 70Neutral | |
| Veeva Systems | 4.88% | $77.27M | $48.82B | 3.37% | 66Neutral | |
| Humana | 4.75% | $75.18M | $54.05B | 90.08% | 69Neutral | |
| Cigna | 4.51% | $71.36M | $78.26B | 9.64% | 72Outperform | |
| Centene | 4.28% | $67.74M | $35.28B | 97.48% | 58Neutral | |
| Labcorp Holdings | 3.65% | $57.81M | $30.08B | 38.31% | 71Outperform | |
| Quest Diagnostics | 3.48% | $55.13M | $28.56B | 38.39% | 79Outperform |
IHF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IHF, the sentiment is Positive. The current price of 60.41 is above the 20-day moving average (MA) of 59.93, above the 50-day MA of 57.80, and above the 200-day MA of 52.08, indicating a bullish trend. The MACD of 0.70 indicates Positive momentum. The RSI at 58.79 is Neutral, neither overbought nor oversold. The STOCH value of 66.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IHF.
IHF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $60.41 | $65.00(7.60% Upside) | $1.58B | 0.37% | 69Neutral | |
| $78.95 | $85.46(8.24% Upside) | $4.86B | 0.37% | 73Outperform | |
| $90.00 | $99.69(10.77% Upside) | $4.12B | 0.08% | 71Outperform | |
| $58.02 | $63.94(10.21% Upside) | $4.03B | 0.37% | 74Outperform | |
| $271.03 | $343.00(26.55% Upside) | $3.08B | 0.55% | 71Outperform | |
| $111.03 | $128.59(15.81% Upside) | $1.72B | 0.37% | 70Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IHF | iShares U.S. Healthcare Providers ETF | 60.41 | 13.33 | 28.31% | |
| IYH | iShares U.S. Healthcare ETF | 78.95 | 15.94 | 25.30% | |
| FHLC | Fidelity MSCI Health Care Index ETF | 90.00 | 18.24 | 25.42% | |
| IHI | iShares U.S. Medical Devices ETF | 58.02 | -3.38 | -5.51% | |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 271.03 | 70.80 | 35.36% | |
| IHE | iShares U.S. Pharmaceuticals ETF | 111.03 | 31.22 | 39.13% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
